Nyhetsflöde
Regulatoriska pressmeddelanden
@OrexoABpubl
26 maj 2023
Glad to have these colleagues presenting the amorphOX® drug delivery platform at the Novel Nasal Formulation & Deli… https://t.co/bLVUITar8c
@OrexoABpubl
24 maj 2023
Tomorrow we will join Bolagsdagen hosted by Erik Penser Bank. An IRL event with more than 300 participants + 60 pre… https://t.co/l2M5u5w8CO
@OrexoABpubl
22 maj 2023
Our partner @gesynta Pharma is developing a novel treatment for #endometriosis (phase II). Today they announces the… https://t.co/Ue74yAbNJ1
Europa |
USA |
 |
|
|
Lena Wange IR & Corporate Communications Director Växel: +46 (0)18 780 88 00 Direktnummer: +46 73 064 16 36 Email: ir@orexo.com Plats: Uppsala, Sverige |
Robert A. DeLuca President Orexo US Inc. Växel: +1 (0)855 982 7658 Email: us.media@orexo.com Plats: New Jersey, US |
